Skip to main content
Sign In

Richard Davis, PhD, (above) and David Bentley, PhD, founded the RNA Bioscience Initiative Researchers in 2016 as part of Dean John Reilly, Jr.'s Transformational Research Funding awards. ​

 

Features



 

Research Programs Boosted with Major Investment

Five recipients of Transformational Research Funding represent major investments in programs that will position the School as a leader in emerging fields.  

 

 






 

Harnessing the Power of the Human Immune System ​

Treating disease by harnessing the power of the human immune system has emerged in recent years as a critical area of inquiry in medical science.  

 


 

RNA Bioscience Initiative Off to Fast Start

Researchers want to expand the RNA expertise of the campus research community and make crucial connections with clinicians and educators to improve diagnostic capabilities and therapeutic breakthroughs to improve human health. 

 

 






 

Maximizing Technology’s Impact in the Doctor-Patient Relationship​

The Data Science to Patient Value (D2V) initiative, a new multidisciplinary program, could revolutionize the patient experience. 


 









 

Strengthening Connections Between Fibrosis Researchers

The Consortium for Fibrosis Research & Translation aims to unify campus researchers and clinicians who, due to their concentrated focus on a particular organ, may not have recognized similarities of their work.


 










 

Innate Immu​ne Program Builds From Strength 

The GI and Liver Innate Immune Program plans to build on our strengths to expand understanding of some of the fastest-growing diseases. 


 


 

Learning Outside the Walls of Medical School​

Anschutz Medical Campus students are partnering with community groups to work closely with neighboring residents on research projects. 

 

 


 

Using Technology to Combat Opioid Epidemic

A CU doctor has developed a pilot project that links data bases to help fight opioid misuse. 

 

 


 

Exercise Expert Offers His Take on Lactate​

Lactate , a metabolic byproduct that accumulates during exercise, is needed for cancer development, says a CU scientist. That may be why athletes get cancer less often than nono-athletes.

 

 


 

In the News

Media from around the country turn to the CU School of Medicine for expertise.

 

 


​​